Universe Pharmaceuticals INC Deferred Tax Assets, Tax Deferred Expense
Universe Pharmaceuticals INC (UPC) had Deferred Tax Assets, Tax Deferred Expense of $656.98 thousand as of 2023-09-30, per its 20-F filed 2024-01-30.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2024-01-30
- 2023-09-30: Deferred Tax Assets, Tax Deferred Expense $656.98K.
- 2022-09-30: Deferred Tax Assets, Tax Deferred Expense $1.35M.
| Period end | Deferred Tax Assets, Tax Deferred Expense |
|---|---|
| 2023-09-30 | $656.98K 20-F · filed 2024-01-30 |
| 2022-09-30 | $1.35M 20-F · filed 2024-01-30 |